Cancer biomarkers: selecting the right drug for the right patient.
about
Radioprotectors and Radiomitigators for Improving Radiation Therapy: The Small Business Innovation Research (SBIR) Gateway for Accelerating Clinical Translation.Biomarker-Guided Adaptive Trial Designs in Phase II and Phase III: A Methodological ReviewBridging academic science and clinical research in the search for novel targeted anti-cancer agentsPredictive biomarkers for treatment selection: statistical considerationsStatistical Methods for Establishing Personalized Treatment Rules in OncologyOn the Slow Diffusion of Point-of-Care Systems in Therapeutic Drug MonitoringEpidermal growth factor receptor immunohistochemistry: new opportunities in metastatic colorectal cancerMachine learning prediction of cancer cell sensitivity to drugs based on genomic and chemical propertiesA novel color change mechanism for breast cancer biomarker detection: naphthoquinones as specific ligands of human arylamine N-acetyltransferase 1Improving drug discovery with high-content phenotypic screens by systematic selection of reporter cell linesPhosphoproteomics data classify hematological cancer cell lines according to tumor type and sensitivity to kinase inhibitorsA network pharmacology approach to evaluating the efficacy of chinese medicine using genome-wide transcriptional expression data.Bayesian predictive modeling for genomic based personalized treatment selection.StickWRLD as an Interactive Visual Pre-Filter for Canceromics-Centric Expression Quantitative Trait Locus Data.Preparation of protein imprinted materials by hierarchical imprinting techniques and application in selective depletion of albumin from human serumGalectin-4 expression is associated with reduced lymph node metastasis and modulation of Wnt/β-catenin signalling in pancreatic adenocarcinomaIncreased MET Gene Copy Number but Not mRNA Level Predicts Postoperative Recurrence in Patients with Non-Small Cell Lung CancerTumor stress-induced phosphoprotein1 (STIP1) as a prognostic biomarker in ovarian cancerOptimization of personalized therapies for anticancer treatmentMICROFLUIDIC DEVICES FOR LABEL-FREE AND NON-INSTRUMENTED QUANTITATION OF UNAMPLIFIED NUCLEIC ACIDS BY FLOW DISTANCE MEASUREMENT.Reliable quantification of protein expression and cellular localization in histological sections.In-silico prediction of key metabolic differences between two non-small cell lung cancer subtypesCancer3D: understanding cancer mutations through protein structures.FS-93, an Hsp90 inhibitor, induces G2/M arrest and apoptosis via the degradation of client proteins in oncogene addicted and derived resistant cancer cells.Cancer biomarker discovery and validation.Biomarker development in the context of urologic cancersSpecificity of Genetic Biomarker Studies in Cancer Research: A Systematic Review.Mining the Breast Cancer Proteome for Predictors of Drug Sensitivity.Harnessing the PI3K/Akt/mTOR pathway in T-cell acute lymphoblastic leukemia: eliminating activity by targeting at different levelsAn expanding role for cell biologists in drug discovery and pharmacology.Personalized medicine and pharmacogenetic biomarkers: progress in molecular oncology testing.Direct regulation of E-cadherin by targeted histone methylation of TALE-SET fusion protein in cancer cellsRepeatability of 18F-FDG PET/CT in Advanced Non-Small Cell Lung Cancer: Prospective Assessment in 2 Multicenter Trials.MERAV: a tool for comparing gene expression across human tissues and cell types.Role of CYB5A in pancreatic cancer prognosis and autophagy modulationBiomarker identification in breast cancer: Beta-adrenergic receptor signaling and pathways to therapeutic response.Herceptin resistance database for understanding mechanism of resistance in breast cancer patients.Biomarker-Guided Non-Adaptive Trial Designs in Phase II and Phase III: A Methodological Review.DNA Adducts from Anticancer Drugs as Candidate Predictive Markers for Precision Medicine.A Microfluidic Immunostaining System Enables Quality Assured and Standardized Immunohistochemical Biomarker Analysis.
P2860
Q24282585-F724F010-0BD3-4ABE-B0AB-5E8032DD06FEQ26766584-F86B7CB8-81D0-4FF5-9F78-FA7542724FE7Q26771396-532CF3B3-55F7-422D-848B-3403BEC2D3EBQ26778367-D3011B6D-0411-4245-AEEC-0F1EC2B9F6BCQ26786366-9EFB5370-3DB9-4D9F-BE3F-EE87AB958C35Q27024074-99DDDC55-FBCC-46C9-AEBF-0D09A437D8F1Q28084216-9326122E-2B93-44CA-9E23-0695B8E184BFQ28487333-D9FB4432-1A86-448E-AB4D-DD69CCC59E44Q28535117-A6623039-9DEB-456E-B089-82BB750D0DADQ28834223-564BA3B7-DAFD-4D1A-9A80-938CD86C9078Q30620482-5E93DD4E-6D49-4EE5-9091-22DC564FC342Q30640970-52A41AA5-7CB5-4557-8D0E-4EF95AF2C959Q30758322-8D06AC5E-EDE6-4437-AF5F-8AE55B4544A4Q30867387-11BA1E89-D5AE-4F25-8BD9-CFADF9306403Q33820169-EC5EFF16-606B-4D0A-B414-EDD70CF52FB6Q34221829-92B0712C-5F0B-42D1-B6AF-B995AA46E501Q34478374-72CAFCCA-D74E-4453-89A6-6D3278679B38Q34611741-1020D634-EB17-49A8-B1B1-0FF2E4EBA484Q34669425-220454C8-6DC6-4FB8-B955-B32CCB449511Q34723111-1B3875C4-F75B-4BE4-A981-54966F9968C6Q35205192-E363E66D-ABB3-4727-B3B3-0202171ACCA3Q35219399-1340F40C-0414-4E57-B799-3ABE2CA7751CQ35253926-8C46324A-DFB3-4FF7-AE78-C7A4AF6D4DDBQ35745004-4277D333-DD9F-468B-8EDE-877E3C220B30Q35879887-6DCA789C-829E-4CF5-8AF3-A7FABE5CB8F8Q35906352-C5A994F1-D995-4D6E-9C2C-6DD23FB11C7EQ36068850-CC81E6BB-7B95-46C0-AB1E-DF00725A50DCQ36210404-5A12C528-77D9-4A95-85DF-9F192B10E736Q36339232-4C8D876C-3320-4790-A039-A604306106E8Q36356498-EB6BA147-0568-47B6-BA29-24F27E3683D8Q36392598-1D9CE2C2-4B1B-4C41-BF03-6F99F37F5258Q36414312-BF8CBEF7-3E72-4E7A-A475-ABF1B9E011BFQ36425061-CCA6F8DF-A63A-44F8-BF80-2C085AFE944AQ36435039-916E7520-5565-4E1F-BD75-63ECC3BD610FQ37532658-A8FF71C5-45F6-415C-9C48-24089B94DCC9Q37654991-2C756994-9B8F-40E6-831A-F22EA112F0E7Q37666730-0279CE88-1ED0-49A1-B5E7-B92DFEA7C1ECQ37731264-5DC174BF-0BD9-45B6-9A75-8A5513222CDFQ37736567-405BF521-DCB7-418B-A9B0-90E158A6268CQ37737860-940860D4-763A-4A4B-9041-4355890AC246
P2860
Cancer biomarkers: selecting the right drug for the right patient.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Cancer biomarkers: selecting the right drug for the right patient.
@en
Cancer biomarkers: selecting the right drug for the right patient.
@nl
type
label
Cancer biomarkers: selecting the right drug for the right patient.
@en
Cancer biomarkers: selecting the right drug for the right patient.
@nl
prefLabel
Cancer biomarkers: selecting the right drug for the right patient.
@en
Cancer biomarkers: selecting the right drug for the right patient.
@nl
P356
P1476
Cancer biomarkers: selecting the right drug for the right patient.
@en
P2093
Caroline C Sigman
Gary J Kelloff
P2888
P304
P356
10.1038/NRD3651
P577
2012-02-10T00:00:00Z